AGP Limited (PSX:AGP)
199.45
+1.42 (0.72%)
At close: Sep 26, 2025
AGP Limited Revenue
AGP Limited had revenue of 5.56B PKR in the quarter ending June 30, 2025, a decrease of -2.86%. This brings the company's revenue in the last twelve months to 26.11B, up 17.10% year-over-year. In the year 2024, AGP Limited had annual revenue of 25.03B with 33.56% growth.
Revenue (ttm)
26.11B
Revenue Growth
+17.10%
P/S Ratio
2.14
Revenue / Employee
12.18M
Employees
2,143
Market Cap
55.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25.03B | 6.29B | 33.56% |
Dec 31, 2023 | 18.74B | 4.28B | 29.63% |
Dec 31, 2022 | 14.46B | 5.14B | 55.19% |
Dec 31, 2021 | 9.32B | 2.37B | 34.12% |
Dec 31, 2020 | 6.95B | 693.12M | 11.08% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 62.62B |
Abbott Laboratories (Pakistan) | 72.39B |
Highnoon Laboratories | 25.78B |
The Searle Company | 29.12B |
Shifa International Hospitals | 27.97B |
Citi Pharma | 12.97B |
Macter International | 8.48B |
Ferozsons Laboratories | 18.86B |